PMC · DOI:10.1016/j.jdcr.2025.10.010·October 14, 2025
Novel use of deucravacitinib for treatment of recalcitrant TIF1-gamma dermatomyositis
Anuk Burli, Benjamin Gallo Marin, Elan Newman, Zunera Tahir, David F. Fiorentino
Abstract
Linked entities
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Figures2
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsInflammatory Myopathies and Dermatomyositis · Systemic Sclerosis and Related Diseases · Skin Diseases and Diabetes